Your browser doesn't support javascript.
loading
Clinical validation and utility of Percepta GSC for the evaluation of lung cancer.
Mazzone, Peter; Dotson, Travis; Wahidi, Momen M; Bernstein, Michael; Lee, Hans J; Feller Kopman, David; Yarmus, Lonny; Whitney, Duncan; Stevenson, Christopher; Qu, Jianghan; Johnson, Marla; Walsh, P Sean; Huang, Jing; Lofaro, Lori R; Bhorade, Sangeeta M; Kennedy, Giulia C; Spira, Avrum; Rivera, M Patricia.
Affiliation
  • Mazzone P; Department of Pulmonary Medicine, Cleveland Clinic, Respiratory Institute, Cleveland, OH, United States of America.
  • Dotson T; Division of Pulmonary and Critical Care, Wake Forest Baptist Health, Winston-Salem, NC, United States of America.
  • Wahidi MM; Division of Pulmonary, Allergy & Critical Care Medicine, Duke University Medical Center, Durham, NC, United States of America.
  • Bernstein M; Stamford Health Medical Group, Pulmonary, Stamford Hospital, Stamford, CT, United States of America.
  • Lee HJ; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, United States of America.
  • Feller Kopman D; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, United States of America.
  • Yarmus L; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, United States of America.
  • Whitney D; Head of Early Detection Lung Cancer Initiative, Johnson & Johnson, Boston, MA, United States of America.
  • Stevenson C; Head of Pharmaceutical Sciences, Lung Cancer Initiative, Johnson & Johnson, London, United Kingdom.
  • Qu J; Research and Development, Veracyte, Inc, San Francisco, CA, United States of America.
  • Johnson M; Research and Development, Veracyte, Inc, San Francisco, CA, United States of America.
  • Walsh PS; Research and Development, Veracyte, Inc, San Francisco, CA, United States of America.
  • Huang J; Research and Development, Veracyte, Inc, San Francisco, CA, United States of America.
  • Lofaro LR; Clinical Operations, Veracyte, Inc, San Francisco, CA, United States of America.
  • Bhorade SM; Medical Affairs, Veracyte, Inc, San Francisco, CA, United States of America.
  • Kennedy GC; Research and Development, Clinical Operations, Medical Affairs, Veracyte, Inc, South San Francisco, CA, United States of America.
  • Spira A; Division of Pulmonary and Critical Care Medicine, Boston University Medical Center, Boston, MA, United States of America.
  • Rivera MP; Division of Pulmonary and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
PLoS One ; 17(7): e0268567, 2022.
Article in En | MEDLINE | ID: mdl-35830375
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bronchoscopy / Lung Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bronchoscopy / Lung Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos